KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Gains from Sales and Divestitures (2019 - 2025)

BioNTech SE's Gains from Sales and Divestitures history spans 6 years, with the latest figure at -$452783.9 for Q2 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 110.23% to -$452783.9 in Q2 2025 year-over-year; TTM through Jun 2025 was -$452783.9, a 110.23% decrease, with the full-year FY2021 number at $5.26, up 635.6% from a year prior.
  • Gains from Sales and Divestitures hit -$452783.9 in Q2 2025 for BioNTech SE, down from -$215377.5 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for BNTX hit a ceiling of $481708.6 in Q2 2021 and a floor of -$452783.9 in Q2 2025.
  • Historically, Gains from Sales and Divestitures has averaged $4494.0 across 4 years, with a median of $2.75 in 2021.
  • Biggest five-year swings in Gains from Sales and Divestitures: soared 635.6% in 2021 and later crashed 110.23% in 2025.
  • Tracing BNTX's Gains from Sales and Divestitures over 4 years: stood at $5.26 in 2021, then soared by 4055402.37% to $213411.3 in 2022, then tumbled by 200.92% to -$215377.5 in 2024, then tumbled by 110.23% to -$452783.9 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for BNTX at -$452783.9 in Q2 2025, -$215377.5 in Q2 2024, and $213411.3 in Q2 2022.